FHR4: Age-Related Macular Degeneration Breakthrough

Almost 2 million Americans have age-related macular degeneration (AMD), where the cells in the retina, which is the layer of tissue in the back of the eye, break down, causing central vision to become blurry. Over time, 100,000 of those will become blind.

An international team of scientists has identified a protein, FHR4, which is strongly linked to AMD when its levels are raised in the blood. The findings were confirmed in 484 patient and 522 control samples from two independent collections across Europe. FHR4 is one of a group of proteins that regulate the complement system and the genes encoding these proteins are tightly clustered on chromosome 1, the largest human chromosome.

Analyses of eyes donated for research after life also revealed the FHR4 protein was present in the AMD-affected parts of the eye and FHR4 was shown by the team to activate part of the immune system -called the complement system; over activation is a major causal factor of AMD.

Credit: NIH

When the team investigated a set of genetic variants across the human genome, they found that genetic variants in this region on chromosome 1 determined the levels of FHR4 in the blood. And they found that the same genetic variants were associated with AMD.

"We have shown that genetically determined higher blood FHR4 levels leads to more FHR4 in the eye which in turn increases the risk of the uncontrolled immune system response that drives the disease," said Professor Paul Bishop from the University of Manchester. "So apart from improving understanding of how AMD is caused, this work provides a way of predicting risk of the disease by simply measuring blood levels of FHR4."

Categories

More like this

COVID-19 is caused by a coronavirus called SARS-CoV-2. Coronaviruses belong to a group of viruses that infect animals, from peacocks to whales. They’re named for the bulb-tipped spikes that project from the virus’s surface and give the appearance of a corona surrounding it. A coronavirus infection…
In the first-ever (sanctioned) investigational use of multiple edits to the human genome, a study found that cells edited in three specific ways and then removed from patients and brought back into the lab setting were able to kill cancer months after their original manufacturing and infusion.…
In the Yangtze Delta, about 160 kilometres southwest of Shanghai, the archeological ruins of Liangzhu City are located. There, a highly advanced culture blossomed about 5,300 years ago, thanks to the engineering of large hydraulic structures. The walled city had a complex system of navigable…
A new trial has begun in Victoria this week to evaluate a potential vaccine against COVID-19. The vaccine is called NVX-CoV2373 and is from a US biotech company, Novavax. The trial will be carried out across Melbourne and Brisbane, and is the first human trial of a vaccine specifically for COVID-…